Lifecore Biomedical, Inc. De (LFCR) EV to CFO (2010 - 2025)

Lifecore Biomedical has reported EV to CFO for 16 years, with the latest figure at 36.74 in Q2 2025.

• On a quarterly basis, EV to CFO rose 96.08% year-over-year to 36.74 in Q2 2025; TTM through May 2025 was 242.0, a 61.91% decrease from a year earlier, with the FY2025 full-year figure at 1167.72, down 283.77% from the prior year.
• EV to CFO was 36.74 for Q2 2025 at Lifecore Biomedical, down from 168.72 in the prior quarter.
• The five-year high for EV to CFO was 231.55 in Q3 2021, with the low at 302.43 in Q3 2024.
• Average EV to CFO over 5 years is 34.01, with a median of 36.58 recorded in 2023.
• The sharpest annual moves came in 2021 and 2024: EV to CFO soared 1224.96% in 2021, then tumbled 1068.67% in 2024.
• Over 5 years, EV to CFO stood at 53.01 in 2021, then sank by 98.53% to 105.25 in 2022, then surged by 268.74% to 177.6 in 2023, then plunged by 123.92% to 42.49 in 2024, then surged by 186.46% to 36.74 in 2025.
• The last three EV to CFO figures came in at 36.74 (Q2 2025), 168.72 (Q1 2025), and 42.49 (Q4 2024), per Business Quant data.